skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Utilization of preventive care services and their effect on cardiovascular outcomes in the United States

Original Research

(1784) Views  (447) Full article downloads

Authors: Varun Vaidya, Gautam Partha, Jennifer Howe

Published Date January 2011 Volume 2011:4 Pages 1 - 7
DOI: http://dx.doi.org/10.2147/RMHP.S15777

Varun Vaidya, Gautam Partha, Jennifer Howe
Pharmacy Health Care Administration, Department of Pharmacy Practice, University of Toledo College of Pharmacy, Toledo, OH, USA

Objective: To describe and analyze utilization of preventive care services and their effect on cardiovascular outcomes in the United States.
Methods: Data from the 2007 Medical Expenditure Panel Survey (MEPS) were used to analyze utilization of preventive care services and their effect on cardiovascular outcomes. Recommendations by the Seventh Report of the Joint Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure and the National Cholesterol Education Program were used to determine appropriate levels of preventive care utilization. Utilization of blood pressure screening and cholesterol checkup services were used as the dependent variable, while age, gender, race, ethnicity, insurance status, and perceived health status were used as independent variables. Since guidelines differ for people with elevated blood pressure, respondents with elevated blood pressure were identified in the MEPS database by self-reported diagnosis. Descriptive statistics were used to describe the population, while a multivariate logistic regression model was built to predict odds of utilizing appropriate levels of preventive services.
Results: Total number of adult respondents for which data were available for blood pressure checkup and cholesterol checkup was 20,523 and 15,784, respectively. Overall, MEPS respondents were found to adhere to guideline recommendations for preventive care utilization. Multivariate logistic regression showed that odds of utilization of preventive care services were higher for elderly patients (age >65 years) for blood pressure (odds ratio [OR] = 2.39, 95% confidence interval [CI]: 1.92–2.97) and cholesterol (OR = 3.05, 95% CI: 2.18–4.27) preventive services compared with younger population (age 18–54 years). Males had much lower odds of getting blood pressure (OR = 0.33, 95% CI: 0.30–0.37) and cholesterol (OR = 0.59, 95% CI: 0.50–0.70) checks done compared with females. Odds of utilization were nearly similar for all races. Uninsured had lower odds for blood pressure (OR = 0.26, 95% CI: 0.23–0.30) and cholesterol (OR = 0.30, 95% CI: 0.24–0.39) checks compared with privately insured people. Asians had lower odds of getting blood pressure checkups compared to Whites (OR = 0.49, 95% CI: 0.39–0.63). Similar trends were recorded for other covariates such as race and perceived health status.
Conclusion: The study was successful in identifying existing age, race, income, and insurance-status related disparities in preventive care utilization within a US population.

Keywords: guidelines, prevention/screening, gender differences in health and health care, racial/ethnic differences in health and health care




 

Other articles by Dr Varun Vaidya



Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
The benefits and risks of testosterone replacement therapy: a review
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
The role of print advertising in clinical trial recruitment: Lessons from a South African site
Improving health outcomes with better patient understanding and education
Examining the clinical trial feasibility process and its implications for a trial site
Incidence and risk factors of suicide reattempts within 1 year after psychiatric hospital discharge in mood disorder patients
Emerging patient safety issues under health care reform: follow-on biologics and immunogenicity
Multiple causes of death models for human immunodeficiency virus/acquired immune deficiency syndrome and related mortality in South Africa in 2006 and 2007
Is Patch It® better than placebo in alleviating swelling and ache in the lower legs and feet? A randomized, placebo-controlled, double blind, crossover, sequential trial